PCH
Polar Capital Holdings Portfolio holdings
AUM
$20.7B
1-Year Est. Return
81.27%
1 Year Est. Return
+81.27%
AUM
$20.7B
AUM Growth
+$1.68B
(+8.8%)
Holding
309
Top Buys
| 1 | +$222M | |
| 2 | +$196M | |
| 3 | +$193M | |
| 4 |
TTM Technologies
TTMI
|
+$176M |
| 5 |
Applovin
APP
|
+$153M |
Top Sells
| 1 | +$279M | |
| 2 | +$216M | |
| 3 | +$208M | |
| 4 |
Spotify
SPOT
|
+$192M |
| 5 |
CyberArk
CYBR
|
+$172M |
Sector Composition
| 1 | Technology | 48.6% |
| 2 | Financials | 15.7% |
| 3 | Healthcare | 14.87% |
| 4 | Communication Services | 10.81% |
| 5 | Consumer Discretionary | 5.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RAPP
126
Rapport Therapeutics
RAPP
$1.31B
| $27.9M | 0.13% |
+938,952
|
|
||
127
Tencent Music
TME
$25.6B
| $27.8M | 0.13% |
+1,190,843
|
|
||
128
Jones Lang LaSalle
JLL
$16.7B
| $27.7M | 0.13% |
92,753
+51,243
|
|
||
129
Thermo Fisher Scientific
TMO
$234B
| $27.6M | 0.13% |
+56,824
|
|
||
130
BBB Foods
TBBB
$3.61B
| $26.6M | 0.13% |
985,507
-30,527
|
|
||
131
Exact Sciences
EXAS
$19.4B
| $25.6M | 0.12% |
467,134
+160,202
|
|
||
132
JFrog
FROG
$6.67B
| $25.1M | 0.12% |
529,836
+311,410
|
|
||
133
Edwards Lifesciences
EW
$48.2B
| $24.7M | 0.12% |
317,886
+63,208
|
|
||
134
Steris
STE
$25.9B
| $24.6M | 0.12% |
+99,504
|
|
||
135
Analog Devices
ADI
$146B
| $24.1M | 0.12% |
97,947
-2,705
|
|
||
136
Cenovus Energy
CVE
$34.7B
| $23.1M | 0.11% |
1,094,259
+44,966
|
|
||
137
Penumbra
PEN
$12.3B
| $23M | 0.11% |
90,877
+24,504
|
|
||
138
McKesson
MCK
$103B
| $22.8M | 0.11% |
29,476
-113
|
|
||
139
Globant
GLOB
$2.99B
| $22.5M | 0.11% |
391,977
-10,249
|
|
||
140
Kymera Therapeutics
KYMR
$6.02B
| $22.5M | 0.11% |
397,041
+147,041
|
|
||
141
Qualcomm
QCOM
$173B
| $22.4M | 0.11% |
134,402
+4,138
|
|
||
142
Revolution Medicines
RVMD
$23.4B
| $22.3M | 0.11% |
478,105
-273,550
|
|
||
143
Mastercard
MA
$491B
| $22.2M | 0.11% |
38,944
-15,738
|
|
||
144
Fidelity National Information Services
FIS
$33.1B
| $21.9M | 0.11% |
332,258
-36,391
|
|
||
145
Marvell Technology
MRVL
$68.2B
| $21.9M | 0.11% |
260,000
+27,000
|
|
||
146
Apogee Therapeutics
APGE
$5.52B
| $20.8M | 0.1% |
524,094
+29,094
|
|
||
147
DexCom
DXCM
$27B
| $20.8M | 0.1% |
+308,478
|
|
||
148
Xometry
XMTR
$3.26B
| $20.4M | 0.1% |
374,991
-57,796
|
|
||
|
ORKA
149
Oruka Therapeutics
ORKA
$1.55B
| $19.9M | 0.1% |
1,032,307
+57,307
|
|
||
150
Bank of America
BAC
$379B
| $19.8M | 0.1% |
384,376
-41,595
|
|